Injective and Bitoro to Launch Cost-Effective Futures Trading Platform
The post Injective and Bitoro to Launch Cost-Effective Futures Trading Platform appeared on BitcoinEthereumNews.com. Injective Protocol and Bitoro Network are teaming up to unveil a groundbreaking on-chain perpetual futures platform. It sets to launch tomorrow, June 13, at 10 am ET. This collaboration aims to provide instant and cost-effective trading options for institutional-grade real-world assets (RWA) and cryptocurrency futures. Bitoro Network Surpasses 30,000 Users Within Two Months Launched less than two months ago, Bitoro Network has already attracted over 30,000 users. With trading volume exceeding $1bn, making it the fastest growing decentralized futures exchange on the market. Together, Bitoro and Injective have strategic aspirations to become the foremost on and off-chain trading platforms competing against leading providers based on various features. These include fees, speed, and reliability. Injective integration with Bitoro Network vastly expands its offering of decentralized perpetual futures platform. By integrating with Injective’s powerful blockchain infrastructure and its unique on-chain order book, Bitoro expands its offerings to include new trading pairs and low fees. It also offers staking vaults and solutions specifically designed for institutions. With Injective providing Bitoro with comprehensive on-chain perpetual markets for virtually any asset, including real-world assets such as forex pairs, commodities. Bitoro also leverages Injective’s shared liquidity pool on-chain resulting in increased market depth and liquidity for the trading pairs. In addition, Bitoro would be in a position to benefit from the institutional-quality infrastructure and security measures of Injective. This makes it easier for institutional clients to conform to global standards and integrate with the existing trading infrastructure. It is supported by more than 60 top-tier global institutions securing Injective’s network as validators. Bitoro CEO Brian Purcell Excited for Injective Partnership Brian Purcell is founder and CEO of Bitoro Network. He added that Bitoro is excited to join forces with Injective. The architecture of Injective improves Bitoro’s offerings. It will bring cutting-edge features like institutional gateways and…
The post Injective and Bitoro to Launch Cost-Effective Futures Trading Platform appeared on BitcoinEthereumNews.com.
Injective Protocol and Bitoro Network are teaming up to unveil a groundbreaking on-chain perpetual futures platform. It sets to launch tomorrow, June 13, at 10 am ET. This collaboration aims to provide instant and cost-effective trading options for institutional-grade real-world assets (RWA) and cryptocurrency futures. Bitoro Network Surpasses 30,000 Users Within Two Months Launched less than two months ago, Bitoro Network has already attracted over 30,000 users. With trading volume exceeding $1bn, making it the fastest growing decentralized futures exchange on the market. Together, Bitoro and Injective have strategic aspirations to become the foremost on and off-chain trading platforms competing against leading providers based on various features. These include fees, speed, and reliability. Injective integration with Bitoro Network vastly expands its offering of decentralized perpetual futures platform. By integrating with Injective’s powerful blockchain infrastructure and its unique on-chain order book, Bitoro expands its offerings to include new trading pairs and low fees. It also offers staking vaults and solutions specifically designed for institutions. With Injective providing Bitoro with comprehensive on-chain perpetual markets for virtually any asset, including real-world assets such as forex pairs, commodities. Bitoro also leverages Injective’s shared liquidity pool on-chain resulting in increased market depth and liquidity for the trading pairs. In addition, Bitoro would be in a position to benefit from the institutional-quality infrastructure and security measures of Injective. This makes it easier for institutional clients to conform to global standards and integrate with the existing trading infrastructure. It is supported by more than 60 top-tier global institutions securing Injective’s network as validators. Bitoro CEO Brian Purcell Excited for Injective Partnership Brian Purcell is founder and CEO of Bitoro Network. He added that Bitoro is excited to join forces with Injective. The architecture of Injective improves Bitoro’s offerings. It will bring cutting-edge features like institutional gateways and…
What's Your Reaction?